Dexamethasone in Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

404

Participants

Timeline

Start Date

October 28, 2021

Primary Completion Date

January 1, 2025

Study Completion Date

May 30, 2025

Conditions
Total Knee Arthroplasty
Interventions
DRUG

Dexamethasone 4mg

4mg intravenous dexamethasone, administered shortly after induction of anesthesia

DRUG

Dexamethasone 8 Mg/mL Injectable Suspension

8mg intravenous dexamethasone, administered shortly after induction of anesthesia

DRUG

Dexamethasone 16mg

16mg intravenous dexamethasone, administered shortly after induction of anesthesia

Trial Locations (10)

10016

NYU Langone Health, New York

10032

Columbia University Irving Medical Center, New York

19104

University of Pennsylvania Perelman School of Medicine, Philadelphia

19107

Jefferson Philadelphia University and Thomas Jefferson University, Philadelphia

55902

Mayo Clinic Institutional Review, Rochester

60612

Rush University medical Center, Chicago

63110

Washington University, St Louis

94063

Stanford University, Redwood City

94158

University of California, San Francisco, San Francisco

02145

Mass General Brigham, Somerville

All Listed Sponsors
lead

Rush University Medical Center

OTHER

NCT05018091 - Dexamethasone in Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter